Studies on the role of the acid sphingomyelinase in multiple sclerosis demonstrated that genetic deficiency of acid sphingomyelinase prevented many aspects of multiple sclerosis, including blood-brain barrier disruption, influx of immune cells into the central nervous system and, thereby, neuroinflammation (1, 2). This evidence concerns the gene SMPD1 and multiple sclerosis.